Correlation Between NYSE Composite and Virax Biolabs
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Virax Biolabs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Virax Biolabs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Virax Biolabs Group, you can compare the effects of market volatilities on NYSE Composite and Virax Biolabs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Virax Biolabs. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Virax Biolabs.
Diversification Opportunities for NYSE Composite and Virax Biolabs
-0.68 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between NYSE and Virax is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Virax Biolabs Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virax Biolabs Group and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Virax Biolabs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virax Biolabs Group has no effect on the direction of NYSE Composite i.e., NYSE Composite and Virax Biolabs go up and down completely randomly.
Pair Corralation between NYSE Composite and Virax Biolabs
Assuming the 90 days trading horizon NYSE Composite is expected to generate 17.74 times less return on investment than Virax Biolabs. But when comparing it to its historical volatility, NYSE Composite is 24.1 times less risky than Virax Biolabs. It trades about 0.11 of its potential returns per unit of risk. Virax Biolabs Group is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 96.00 in Virax Biolabs Group on August 27, 2024 and sell it today you would earn a total of 105.00 from holding Virax Biolabs Group or generate 109.37% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
NYSE Composite vs. Virax Biolabs Group
Performance |
| Timeline |
NYSE Composite and Virax Biolabs Volatility Contrast
Predicted Return Density |
| Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Virax Biolabs Group
Pair trading matchups for Virax Biolabs
Pair Trading with NYSE Composite and Virax Biolabs
The main advantage of trading using opposite NYSE Composite and Virax Biolabs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Virax Biolabs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virax Biolabs will offset losses from the drop in Virax Biolabs' long position.| NYSE Composite vs. Grocery Outlet Holding | NYSE Composite vs. Tencent Music Entertainment | NYSE Composite vs. SunLink Health Systems | NYSE Composite vs. Getty Realty |
| Virax Biolabs vs. Eliem Therapeutics | Virax Biolabs vs. HCW Biologics | Virax Biolabs vs. Scpharmaceuticals | Virax Biolabs vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Stocks Directory Find actively traded stocks across global markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |